# Deciphera Pharmaceuticals funding: rounds and investors > Deciphera Pharmaceuticals has raised $127M across 2 rounds since 2015. Investors include Redmile Group, New Leaf Venture Partners and Viking Global. Source: https://millionrounds.com/company/deciphera-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article) United States · [Series C startup](https://millionrounds.com/companies) # Who invested in *Deciphera Pharmaceuticals* 2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$127M** raised across 2 rounds since 2015, from 2 sources **$75M** Series B **$52M** Series C - **Latest round:** Series C, $52M Jun 2017 - **Biggest round:** $75M Series B · Sept 2015 - **Investors:** 4 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2016 2017 **$75M** Series B **$52M** Series C - **First round:** Series B, $75M - **Biggest round:** $75M - **Between rounds:** 20 months ## The rounds - **Jun 2017** Series C **$52M** *3 new* [Redmile Group](https://millionrounds.com/fund/redmile-group) [Viking Global](https://millionrounds.com/fund/viking-global-investors) Sphera Global/ New Leaf Reported by FinSMEs SEC filing: $52M sold, first sale May 2017 - **Sept 2015** Series B **$75M** *1 new* [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) From a historical funding record SEC filing: $22M sold, first sale Sept 2015 ## Founders and team From Deciphera Pharmaceuticals's own website and the SEC filings it signed: 12 on the team. - **Ryota Udagawa** President & Chief Executive Officer - **Annah Litzenberger** Chief Human Resources Officer - **Masahiro Hamada** Chief of Staff - **Akira Imagawa** Head of Research - **Jennifer Strong** Head of Technical Operations - **Peter Habura** Head of Quality Assurance and Pharmacovigilance - **Maria Ostrovsky** General Counsel - **Christopher J. Morl** Executive Officer i - **Daniel L. Flynn** Executive Officer i - **Michael D. Taylor** Executive Officer, Director i - **Oliver L. Rosen** Executive Officer i - **Thomas L. Kelly** Executive Officer i On the board, as filed i *Dennis A. Walsh* *Edward J. Benz* *James A. Bristol* *John A. Martin* *Liam A. Ratcliffe* *Michael A. Ross* *Patricia L. Allen* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2015 **Series C** 2017 [Redmile Group](https://millionrounds.com/fund/redmile-group) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) [Viking Global](https://millionrounds.com/fund/viking-global-investors) Sphera Global/ New Leaf ## Everyone who backed them [Redmile Group](https://millionrounds.com/fund/redmile-group) VC firm **1** round [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) VC firm **1** round [Viking Global](https://millionrounds.com/fund/viking-global-investors) VC firm **1** round Sphera Global/ New Leaf no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=deciphera-pharmaceuticals). ## Also claim to have backed them This firm lists Deciphera Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Frazier Life Sciences](https://millionrounds.com/fund/frazier-life-sciences) VC firm Per its own site ## Quick answers about Deciphera Pharmaceuticals ### Who invested in Deciphera Pharmaceuticals? Deciphera Pharmaceuticals's investors include Redmile Group, New Leaf Venture Partners, Viking Global and Sphera Global/ New Leaf. ### How much has Deciphera Pharmaceuticals raised? Deciphera Pharmaceuticals has raised $127M across 2 rounds since 2015. ### When did Deciphera Pharmaceuticals last raise? Deciphera Pharmaceuticals's most recent round was a Series C of $52M in Jun 2017. ### What was Deciphera Pharmaceuticals's biggest round? Deciphera Pharmaceuticals's largest round on record is $75M (Series B), in Sept 2015. ### Who backed Deciphera Pharmaceuticals first? Deciphera Pharmaceuticals's first round on record, in Sept 2015, was backed by New Leaf Venture Partners. ### What stage is Deciphera Pharmaceuticals at? Deciphera Pharmaceuticals's latest named round is a Series C, in Jun 2017. ### Where is Deciphera Pharmaceuticals based? Deciphera Pharmaceuticals is based in the United States. ## Companies like Deciphera Pharmaceuticals In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app